Targeting of Neuropharmaceuticals by Chemical Delivery Systems

作者: Nicholas Bodor , Peter Buchwald

DOI: 10.1002/9783527611225.CH20

关键词: MedicinePharmacologyDrug delivery to the brainTargeted drug deliveryBlood–brain barrier

摘要:

参考文章(251)
Nicholas Bodor, Peter Buchwald, Brain-Targeted Drug Delivery American Journal of Drug Delivery. ,vol. 1, pp. 13- 26 ,(2003) , 10.2165/00137696-200301010-00002
Quentin R. Smith, Quantitation of Blood-Brain Barrier Permeability Implications of the Blood-Brain Barrier and Its Manipulation. pp. 85- 118 ,(1989) , 10.1007/978-1-4613-0701-3_4
William J. Millard, Teresa M. Romano, Nicholas Bodor, James W. Simpkins, Growth Hormone (GH) Secretory Dynamics in Animals Administered Estradiol Utilizing a Chemical Delivery System Pharmaceutical Research. ,vol. 7, pp. 1011- 1018 ,(1990) , 10.1023/A:1015982815094
V Beral, P Appleby, E Banks, G Reeves, Use of HRT and the subsequent risk of cancer. Journal of Epidemiology and Biostatistics. ,vol. 4, pp. 191- 210 ,(1999)
Marcus E. Brewster, Cynthia Robledo-Luiggi, Akio Miyakeb, Emil Pop, Nicholas Bodor, Brain-Enhanced Delivery of Anti-Dementia Drugs Springer, Boston, MA. pp. 173- 183 ,(1989) , 10.1007/978-1-4684-5727-8_16
Michael Gütschow, Thomas Hecker, Andrea Thiele, Sunna Hauschildt, Kurt Eger, Aza analogues of thalidomide: synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro. Bioorganic & Medicinal Chemistry. ,vol. 9, pp. 1059- 1065 ,(2001) , 10.1016/S0968-0896(00)00323-0
C. Anthony Hunt, Roderick D. MacGregor, Ronald A. Siegel, Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations. Pharmaceutical Research. ,vol. 3, pp. 333- 344 ,(1986) , 10.1023/A:1016332023234